echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > AJG: Epidemiology and outcome analysis of colorectal cancer associated with inflammatory bowel disease

    AJG: Epidemiology and outcome analysis of colorectal cancer associated with inflammatory bowel disease

    • Last Update: 2023-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Inflammatory bowel disease (IBD) is associated with an increased risk of colon-associated colorectal cancer (CRC), and although IBD accounts for a relatively small percentage of the total burden of CRC, it accounts for a relatively high
    share of CRC-related deaths.
    IBD-associated CRC (IBD-CRC) has different tumor and patient-related factors
    than sporadic CRC.
    Although large population data are scarce, there is some evidence that IBD-CRC cases tend to be younger, tend to be more common in the right colon, and are associated with a poorer prognosis, and this study investigates the epidemiology of IBD-CRC and its outcomes
    .

    This study analysed using population data from the UK National Health Service held in the CRC database to include all CRCs diagnosed with IBD (Crohn's disease, ulcerative colitis, IBD unclassified, and IBD with cholangitis) between 2005 and 2018
    .
    Use descriptive analysis and logistic regression models to compare the features of two groups and their results
    for up to 2 years.

    The results of the study showed that 390614 cases were included with a diagnosis of CRC, of which 5141 (1.
    3%) were also previously diagnosed with IBD
    。 IBD-CRC cases were younger (median age [interquartile] 66 [54-76] vs 72 [63-79] years [P<0.
    01]), more likely to have an urgent diagnosis of CRC (25.
    1% vs 16.
    7% [P<0.
    01]), and more likely to have a right-sided colon tumor (37.
    4% vs 31.
    5% [P<0.
    01]).

    。 Total colectomy was performed in 36.
    3% of patients with IBD (15.
    4% had Crohn's disease, 44.
    1% had ulcerative colitis, 44.
    5% had unclassified IBD, and 67.
    7% had IBD with cholangitis).

    Simoneistic (3.
    2% vs 1.
    6% P<0.
    01) and metachronous tumors (1.
    7% vs 0.
    9% P<0.
    01) occur twice as frequently in patients with IBD as in patients without IBD
    .

    This study found that IBD-associated CRC occurred in younger patients and had worse
    outcomes than sporadic CRC.
    Therefore, there is an urgent need to find the reasons for these differences in order to assist
    in screening, monitoring, and treatment strategies for CRC and its precursor diseases in this high-risk population.

    Original source:

    Birch, Rebecca J.
    et al.
    Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
    American Journal of Gastroenterology.
    2022.

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.